Role of OX40-OX40L interactions in the immune response to solid organ allografts
<p>Transplantation is the treatment of choice for end stage organ failure however current immunosuppressive therapies whilst effective at preventing acute allograft rejection, fail to prevent late graft loss due to chronic rejection and are associated with an increased risk of infection and ma...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2013
|
| Subjects: |
| _version_ | 1797109456511696896 |
|---|---|
| author | Kinnear, G |
| author2 | Jones, N |
| author_facet | Jones, N Kinnear, G |
| author_sort | Kinnear, G |
| collection | OXFORD |
| description | <p>Transplantation is the treatment of choice for end stage organ failure however current immunosuppressive therapies whilst effective at preventing acute allograft rejection, fail to prevent late graft loss due to chronic rejection and are associated with an increased risk of infection and malignancy. Therefore there is a clear unmet clinical need for improved strategies to prevent allograft rejection.</p> <p>OX40 is a member of the TNFR superfamily that has potent costimulatory properties. Although the impact of blockade of the OX40-OX40L pathway has been well documented in models of autoimmune disease, its effect on the rejection of allografts is less well defined. Therefore the aim of this thesis was to determine the impact of OX40 blockade on conventional and regulatory T cell responses to allografts.</p> <p>We found that activation of CD4+ and CD8+ naïve and memory T cells resulted in the induction of OX40 expression and that blockade of OX40-OX40L interactions partially inhibited the response of alloreactive T cells in vitro and prevented skin allograft rejection but did not result in the induction of tolerance. OX40 blockade was found to have no effect on the activation and proliferation of T cells but rather effector T cells failed to accumulate and migrate to skin allografts. This was shown to be the result of an enhanced degree of cell death amongst proliferating effector cells.</p> <p>In addition, blockade of OX40-OX40L interactions at a time of exposure to alloantigen resulted in a pool of Treg with an enhanced ability to suppress T cell responses to alloantigen in vitro and in vivo. Counter-intuitively, OX40 blockade was found to increase the potency of alloreactive Treg by promoting survival following re-activation.</p> <p>Finally, although OX40 blockade impacted both conventional and regulatory T cell responses, anti-OX40 administration did not promote skin or heart allograft survival in immunocompetent recipients and failed to synergise with blockade of other costimulatory molecules to prevent allograft rejection. In conclusion, these data demonstrate that blockade of OX40-OX40L interactions can attenuate naïve and memory T cell responses to alloantigen whilst promoting the survival of alloreactive Treg. Therefore, we propose that anti-OX40 would be a worthwhile adjunct to pre-existing strategies to induce tolerance.</p> |
| first_indexed | 2024-03-07T07:42:10Z |
| format | Thesis |
| id | oxford-uuid:3a1f1658-eed2-4d5f-9331-d0ed884ec7ca |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:42:10Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:3a1f1658-eed2-4d5f-9331-d0ed884ec7ca2023-05-04T16:33:20ZRole of OX40-OX40L interactions in the immune response to solid organ allograftsThesishttp://purl.org/coar/resource_type/c_db06uuid:3a1f1658-eed2-4d5f-9331-d0ed884ec7caTransplantationImmunologyEnglishOxford University Research Archive - Valet2013Kinnear, GJones, NWood, K<p>Transplantation is the treatment of choice for end stage organ failure however current immunosuppressive therapies whilst effective at preventing acute allograft rejection, fail to prevent late graft loss due to chronic rejection and are associated with an increased risk of infection and malignancy. Therefore there is a clear unmet clinical need for improved strategies to prevent allograft rejection.</p> <p>OX40 is a member of the TNFR superfamily that has potent costimulatory properties. Although the impact of blockade of the OX40-OX40L pathway has been well documented in models of autoimmune disease, its effect on the rejection of allografts is less well defined. Therefore the aim of this thesis was to determine the impact of OX40 blockade on conventional and regulatory T cell responses to allografts.</p> <p>We found that activation of CD4+ and CD8+ naïve and memory T cells resulted in the induction of OX40 expression and that blockade of OX40-OX40L interactions partially inhibited the response of alloreactive T cells in vitro and prevented skin allograft rejection but did not result in the induction of tolerance. OX40 blockade was found to have no effect on the activation and proliferation of T cells but rather effector T cells failed to accumulate and migrate to skin allografts. This was shown to be the result of an enhanced degree of cell death amongst proliferating effector cells.</p> <p>In addition, blockade of OX40-OX40L interactions at a time of exposure to alloantigen resulted in a pool of Treg with an enhanced ability to suppress T cell responses to alloantigen in vitro and in vivo. Counter-intuitively, OX40 blockade was found to increase the potency of alloreactive Treg by promoting survival following re-activation.</p> <p>Finally, although OX40 blockade impacted both conventional and regulatory T cell responses, anti-OX40 administration did not promote skin or heart allograft survival in immunocompetent recipients and failed to synergise with blockade of other costimulatory molecules to prevent allograft rejection. In conclusion, these data demonstrate that blockade of OX40-OX40L interactions can attenuate naïve and memory T cell responses to alloantigen whilst promoting the survival of alloreactive Treg. Therefore, we propose that anti-OX40 would be a worthwhile adjunct to pre-existing strategies to induce tolerance.</p> |
| spellingShingle | Transplantation Immunology Kinnear, G Role of OX40-OX40L interactions in the immune response to solid organ allografts |
| title | Role of OX40-OX40L interactions in the immune response to solid organ allografts |
| title_full | Role of OX40-OX40L interactions in the immune response to solid organ allografts |
| title_fullStr | Role of OX40-OX40L interactions in the immune response to solid organ allografts |
| title_full_unstemmed | Role of OX40-OX40L interactions in the immune response to solid organ allografts |
| title_short | Role of OX40-OX40L interactions in the immune response to solid organ allografts |
| title_sort | role of ox40 ox40l interactions in the immune response to solid organ allografts |
| topic | Transplantation Immunology |
| work_keys_str_mv | AT kinnearg roleofox40ox40linteractionsintheimmuneresponsetosolidorganallografts |